Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL465469 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL5052250 | 0.97 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL465358 | 0.97 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL5052375 | 0.95 | HSD17B10 (0.50) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL9075 | 0.94 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404043 | 0.92 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404078 | 0.92 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404113 | 0.92 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL8616701 | 0.92 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 | |
| SCHEMBL1404074 | 0.92 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1LMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2025-11-20 | — | — | US | claimed |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2025-09-09 | — | — | US | claimed |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2024-03-21 | — | — | US | claimed |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2024-01-02 | — | — | US | claimed |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | claimed |
| EP-4132586-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | Tiba Biotech LLC (US) | 2023-02-15 | — | — | EP | claimed |
| US-10113049-B2 | Thermoplastic resin composition | NIPPON NYUKAZAI CO., LTD. (JP) | 2018-10-30 | — | — | US | claimed |
| US-20150329698-A1 | THERMOPLASTIC RESIN COMPOSITION | NIPPON NYUKAZAI CO., LTD. (JP) | 2015-11-19 | — | — | US | claimed |
| US-20080066644-A1 | Alkylmines, alkanolamine compounds, surfactants, a coloring agent and a solvent; combination results in decreased kogation | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-03-20 | — | — | US | claimed |
| EP-1900785-A1 | Ink Composition for Inkjet Recording | Samsung Electronics Co., Ltd. (KR) | 2008-03-19 | — | — | EP | claimed |
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2025-11-20 | — | — | US | disclosed |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2025-09-09 | — | — | US | disclosed |
| EP-4387607-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | Tiba Biotech LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2024-03-21 | — | — | US | disclosed |
| CN-109789065-B | Cosmetic composition for combating colour loss of dyed material | 因诺斯佩克有限公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20010018129-A1 | Process for producing silica-based film, silica-based film, insulating film, and semiconductor device | JSR CORPORATION (JP) | 2001-08-30 | — | — | US | disclosed |
| EP-1127929-A2 | Composition for film formation, method of film formation, and silica-based film | JSR Corporation (JP) | 2001-08-29 | — | — | EP | disclosed |
| EP-1122770-A2 | Silica-based insulating film and its manufacture | JSR Corporation (JP) | 2001-08-08 | — | — | EP | disclosed |
| EP-1090967-A2 | Composition for film formation, method of film formation, and insulating film | JSR Corporation (JP) | 2001-04-11 | — | — | EP | disclosed |
| EP-1088868-A2 | Composition for film formation, method of film formation, and insulating film | JSR Corporation (JP) | 2001-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | SMN1; SMN2 99/4885ALDH1A1 3422/4885LMNA 449/4885 |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | SMN1; SMN2 122/4885ALDH1A1 3979/4885LMNA 72/4885 |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | SMN1; SMN2 99/4885ALDH1A1 3422/4885LMNA 449/4885 |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | SMN1; SMN2 99/4885ALDH1A1 3422/4885LMNA 449/4885 |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | SMN1; SMN2 99/4885ALDH1A1 3422/4885LMNA 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.